Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Vital Therapies, Inc.

NASDAQ: VTLHealthcare / Biotechnology / USA
0.220000.00Vol 778 1431Y Perf -95.79%
Jan 18th, 2019 16:00
BID0.2200 ASK0.2300
Open0.2300 Previous Close0.2200
Pre-Market0.23 After-Trading0.24
 0.01 4.55%  0.02 9.09%
Target Price
0.50 
Analyst Rating
— 0.00
Potencial %
127.27 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.73 
Earnings Date
12th Mar 2019

Today's Price Range

0.21000.2400

 

52wk Range

0.15009.75

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
4.76%
3 Months
-26.67%
6 Months
-97.40%
1 Year
-95.79%
3 Years
-97.38%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VTL0.22000.00000.00
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.10
Current Ratio
3.30
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.75
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.30
Cash Flow Per Share
-1.14
Price to Tangible Book
0.75
Book Value per Share
0.34
Enterprise Value (in ths.)
-7 104
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-112.14
ROE last 12 Months
-140.44
Return on Assets (5Y Avg)
-106.69
ROA last 12 Months
-118.65
Return on Capital (5Y Avg)
-78.54
ROC last 12 Months
-142.12
Return on invested Capital Q
-59.23
Return on invested Capital Y
-97.20
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.28-
Q02 2018-0.33-0.309.09
Q01 2018-0.34-0.340.00
Q04 2017-0.30-0.35-16.67
Q03 2017-0.30-0.300.00
Q02 2017-0.30-0.293.33
Q01 2017-0.37-0.39-5.41
Q04 2016-0.33-0.37-12.12
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.2417.24Positive
12/2018 QR-0.2411.11Positive
12/2018 FY-1.11-344.00Negative
12/2019 FY-1.189.23Positive
Next Report Date12th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume778 143
Shares Outstanding (in ths.)42 370
Trades Count1 249
Dollar Volume176 074
Avg. Volume1 704 280
Avg. Weekly Volume879 087
Avg. Monthly Volume1 491 677
Avg. Quarterly Volume2 239 394

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

65%35%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News